Y. Yamamoto, F. Miyauchi / Inorganica Chimica Acta 334 (2002) 77ꢁ
/90
79
[{(p-Cymene)RuCl2}{(1,2,3,5-Me4C6H2)RuCl2}(m-
1,8-dpmn)] (7ad) (brown, 59.3%). UVꢁVis (CH2Cl2):
lmax 375, ca. 310(sh) nm. H NMR (CDCl3): d 0.95 (d,
JHH 7.0 Hz, i-Pr,
7.0 Hz, i-Pr, 6H)*a, 0.98 (d, JHH
ratio: A/Bꢀ
3.1. Calc. for C56H59P2Cl4RuRh.CH2Cl2:
C, 55.90 H, 5.02. Found: C, 55.52; H, 4.98%.
/
/
1
[{(p-Cymene)RuCl2}(m-1,8-dpmn)(Cp*IrCl2)]
(9a)
(orange, 58.5%). UVꢁVis (CH2Cl2): lmax 320 nm.
/
ꢀ
/
ꢀ
/
1
FAB mass (m/z): 1194 [(M-Cl)ꢂ]. H NMR (CDCl3):
d 0.96 (d, JHH 7.0
7.0 Hz, i-Pr, 6H)*a, 0.98 (d, JHH
Hz, i-Pr, 6H)*b, 1.29 (d, JPH
2.5 Hz, Cp*, 15H), 1.56
(s, p-Me, 3H), 2.51 (c, CH, 2H), 4.58 (d, JHH 9.0 Hz,
p-cymene, 2H)*a, 4.74 (d, JHH
9.0 Hz, p-cymene,
2H)*a, 5.01 (d, JPH 9.0 Hz, PCH2, 2H)*b, 5.14 (d,
JPH 5.0 Hz, p-
6.5 Hz, PCH2, 2H)*b, 5.31 (d, JHH
cymene, 2H)*a, 5.38 (d, JHH 5.5 Hz, p-cymene, 2H)*b,
6.45ꢁ
7.70 (m, ArH, 26H). 31P{1H} NMR (CDCl3): d
31.3, 31.5 (s, p-cymeneRu), 6.8 (s, Cp*IrP). Isomer
ratio: A/Bꢀ3.1. Calc. for C56H59P2Cl4RuIr: C, 54.72;
6H)*b, 1.49 (s, 5-Me, 3H)*a, 1.53 (s, 5-Me, 3H)*b, 1.73
(s, p-Me of p-cymene, 3H)*a, 1.74 (s, p-Me of p-cymene,
3H)*b, 1.86 (s, 1- and 3-Me, 6H)*a, 1.94 (s, 1- and 3-Me,
6H)*b, 2.50 (c, CH, 1H), 4.33 (s, 4- and 6-H, 2H), 4.55
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
10 Hz, PCH2, 2H)*a, 4.73 (d, JHH
6.0 Hz, PCH2, 2H)*b, 6.45ꢁ
ꢀ
/
5.0 Hz,
ꢀ
/
(d, JPH
C6H4, 2H)*a, 5.13 (d, JPH
7.40 (m, ArH, 26H). 31P{1H} NMR (CDCl3): d 31.2,
31.5 (s, (p-cymene)RuP), 35.8 (s, (1,2,3,5-
Me4C6H2)RuP). Isomer ratio: A/Bꢀ1.8. Calc. for
C56H58P2Cl4Ru2×
CH2Cl.2: C, 56.03; H, 4.95. Found: C,
56.44; H, 5.24%.
[{(p-Cymene)RuCl2}(m-1,8-dpmn)(Cp*RhCl2)] (8a)
(brown, 51.7%). UVꢁVis (CH2Cl2): lmax 395, ca.
340(sh) nm. FAB mass (m/z): 1105 [(M-Cl-1)ꢂ]. 1H
NMR (CDCl3): d 0.96 (d, JHH
7.0 Hz, i-Pr, 6H)*a,
0.98 (d, JHH 4.0 Hz,
7.0 Hz, i-Pr, 6H)*b, 1.29 (d, JPH
Cp*, 15H)*a,b, 1.73 (s, p-Me, 3H)*a, 1.74 (s, p-Me,
3H)*b, 2.50 (c, CH, 1H), 4.57 (d, JHH
9.0 Hz, p-
cymene, 2H)*a, 4.74 (d, JPH 9.0 Hz, PCH2, 2H)*a, 4.98
(d, JHH
9.0 Hz, p-cymene, 2H)*b, 5.14 (d, JPH
Hz, PCH2, 2H)*b, 5.29 (s, CH2Cl2), 5.32 (d, JHH
Hz, p-cymene, 2H)*a, 5.42 (d, JHH
2H)*b, 6.45ꢁ
(CDCl3): d 31.2, 31.5 (s, p-cymeneRu), 35.8 (d,
JRhP 142.0 Hz, RhP). Isomer ratio: A/Bꢀ1.8. Calc.
1.5CH2Cl2: C, 54.50; H, 4.93.
ꢀ
/
ꢀ
/
ꢀ
/
/
ꢀ
/
ꢀ
/
ꢀ
/
/
/
/
/
H, 4.84. Found: C, 54.48; H, 5.17%.
[{(1,2,3-Me3C6H3)RuCl2}(m-1,8-dpmn)(Cp*IrCl2)]
/
(9b) (orange, 66.8%). UVꢁVis (CH2Cl2): lmax approxi-
/
1
mately 360 (sh), 311 nm. H NMR (CD2Cl2): d 1.25 (d,
JPH 2.5 Hz, Cp*,
2.5 Hz, Cp*, 15H)*a, 1.26 (d, JPH
15H)*b, 1.90 (s, 1- and 3-Me, 6H)*a, 1.91 (s, 1- and 3-
Me, 6H)*b, 2.07 (d, JPH 2.5Hz, 2-Me, 3H)*a, 2.08 (d,
JPH 5.4 (m, 4-, 5-, 6-C6H,
2.5 Hz, 2-Me, 3H)*b, 4.25ꢁ
and PCH2), 5.29 (s, CH2Cl2), 6.5ꢁ7.4 (m, ArH, 26H).
31P{1H} NMR (CDCl3): d 5.7, 6.5 (s, Cp*IrP), 34.5,
35.5 (s, RuP). Isomer ratio: A/Bꢀ4.7. Calc. for
0.5CH2Cl2: C, 53.01; H, 4.65. Found:
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
/
ꢀ
/
/
ꢀ
/
ꢀ
/
4.5
5.0
ꢀ
/
/
ꢀ
/
5.0 Hz, p-cymene,
C55H57P2Cl4RuIr×
/
/
7.70 (m, ArH, 26H). 31P{1H} NMR
C, 52.76; H, 4.72%.
[(Cp*RhCl2)(m-1,8-dpmn)(Cp*IrCl2)] (10) (reddish
ꢀ
/
/
brown, 91.7%). UVꢁVis (CH2Cl2): lmax 394, ca.
/
for C56H59P2Cl4RuRh×
/
310(sh) nm. 1H NMR (CDCl3): d 1.26 (d, JPH
Hz, Cp*Ir, 15H), 1.27 (d, JPH 3.5 Hz, Cp*Rh, 15H),
4.65 (b, PCH2, 4H), 5.30 (s, CH2Cl2), 6.4ꢁ7.4 (m, ArH,
26H). 31P{1H} NMR (CDCl3): d 5.23 (s, Cp*IrP), 37.9
(d, JRhH
ꢀ2.5
/
Found: C, 54.67; H, 5.28%.
ꢀ
/
[{1,2,3-Me3C6H3RuCl2}(m-1,8-dpmn)(Cp*RhCl2)]
/
(8b) (yellow, 38.7%). UVꢁ
/
Vis (CH2Cl2): lmax 395, ca.
4.0
Hz, Cp*, 15H)*a,b, 1.91 (s, 1- and 3-Me, 6H)*a, 1.92 (s,
1- and 3-Me, 6H)*b, 2.06 (d, JPH 3.0 Hz, 2-Me, 3H)*a,
2.09 (d, JPH 5.0
3.0 Hz, 2-Me, 3H)*a, 4.29 (d, JHH
Hz, 4,6-Me, 6H)*a, 4.36 (d, JHH
5.0 Hz, 4- and 6-Me,
6H)*b, 4.60 (d, JPH
4.0 Hz, PCH2, 2H), 4.69 (d, JHH
4.0 Hz, PCH2, 2H), 5.92 (t, JHH 5.0 Hz, 5-C6H, 1H),
6.45ꢁ
7.50 (m, ArH, 26H). 31P{1H} NMR (CDCl3): d
36.7, 36.8 (s, (p-cymene)RuP), 39.3 (d, JRhP 143.0 Hz,
Cp*RhP). Isomer ratio: A/Bꢀ1.2. Calc. for
1
340(sh) nm. H NMR (CDCl3): d 1.28 (d, JRhH
ꢀ
/
ꢀ
/
142.0 Hz). Calc. for C56H60P2Cl4RhIr×
/
1.5CH2Cl2: C, 50.80 H, 4.67. Found: C, 50.92; H, 4.23%.
ꢀ
/
ꢀ
/
ꢀ
/
2.2. Preparation of cationic complexes
ꢀ
/
ꢀ
/
ꢀ
/
2.2.1. [{(p-Cymene)RuCl(1,8-dpmn)](OTf) (11a)
A solution of [(p-cymene)RuCl2]2 (72.2 mg, 0.118
mmol) in CH2Cl2 (15 ml) and acetone (5 ml) was stirred
at r.t. for 10 min. Ag(OTf) (70.2 mg, 0.273 mmol) was
added to the solution and then 1,8-dpmn (125.6 mg,
0.239 mmol) was added. After 5 h, the solvent was
removed and the residue was extracted with CH2Cl2,
followed by filtration through the glass filter (G4). The
CH2Cl2 was concentrated and diethylether was added,
ꢀ
/
/
ꢀ
/
/
C55H57P2Cl4RuRh: C, 58.68; H, 5.10. Found: C,
58.83; H, 5.16%.
[(1,2,3,4-Me4C6H2)RuCl2}(m-1,8-dpmn)(Cp*RhCl2)]
(8c) (reddish brown, 73.4%): UVꢁ
/
Vis (CH2Cl2): lmax
4.0 Hz,
Cp*, 15H), 1.62 (s, 1- and 4-Me, 6H)*a, 1.64 (s, 1- and 4-
MeC6, 6H)*b, 2.05 (d, JPH
2.5Hz, 2- and 3-MeC6, 6H),
4.24 (d, JPH 3.0 Hz, PCH2, 4H), 4.36 (d, JPH 3.0 Hz,
PCH2, 4H), 4.54 (d, JPH 9.0 Hz, C6H, 2H), 4.93 (d,
JPH 9.0 Hz, C6H, 2H), 5.29 (s, CH2Cl2), 6.4ꢁ7.5 (m,
ArH, 26H). 31P{1H} NMR (CDCl3): d 33.6 (s, RuP),
35.9 (s, RuP), 39.3 (d, JRhP 143.0 Hz, RhP). Isomer
1
394 nm. H NMR (CDCl3): d 1.28 (d, JPH
ꢀ
/
giving yellow crystals of 11a (105.2 mg, 47.2%). UVꢁ
/
Vis
(CH2Cl2): lmax 360 nm. H NMR (CDCl3): d 0.80 (d,
JHH 6.5 Hz, i-Pr,
6.5 Hz, Me2C, 6H)*a, 0.82 (d, JHH
6H)*b, 1.61 (s, Me, 3H)*aꢂb, 2.20 (sep. JHH
6.5 Hz,
CH, 1H)*b, 2.45 (sep. JHH 6.5 Hz, CH, 1H)*a, 5.01 (d,
2JPH
9.5 Hz, PCH2, 2H), 5.15ꢁ5.85 (c, C6H4, 4H),
5.30 (s, CH2Cl2), 6.8ꢁ
8.0 (m, ArH, 10H). 31P{1H} NMR
(CDCl3): d 31.4 (s)*a, 39.0 (s)*b. Isomer ratio: C/Dꢀ
2.
1
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
ꢀ
/
/
ꢀ
/
/
/
ꢀ
/
/